Trial Profile
A phase I/II study of ISR-050 for advanced cancer patients
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs ISR 50 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 02 Apr 2018 New trial record